Drug Registration: A Necessary but Not Sufficient Condition for Good Quality Drugs
A Preliminary Analysis of Twelve Countries

There is a tacit assumption amongst healthcare workers that all drugs of the same therapeutic type, whether innovator brands, generic brands, or a variety of copies of the product, are interchangeable. While there may be concern that some countries' products are more likely to be counterfeited, if one assumes the product is genuine, then the assumption holds that the product will work.

But anecdotal reports suggest that, even when counterfeits and otherwise obviously degraded or grossly substandard products are identified and removed from any sample set, quality problems remain for some products. Given that western countries source so many drug ingredients from abroad, for instance, up to 80% of the active ingredients in U.S. drugs are now made overseas, news reports of nefarious activity have made westerners wary of drugs produced in emerging economies. A recent Pew Trusts poll indicated that 54% and 70% of Americans distrusted drugs sourced respectively in India and China. But it is not acceptable in international trade law to boycott products based on suspicion alone, nor is it prudent since many drugs made in emerging economies are demonstrably fine and are certainly cheaper than innovator brands.

This working paper is the first part of a project looking at various characteristics, including product variability, of essential drugs in developing and mid-income countries. The publication that will follow this paper will assess actual drug variability; this working paper addresses what is probably a significant driver of drug quality--the legislative environment, and in particular, the registration process in which medicines are made and, more critically, sold. . . .

Read this full paper as an Adobe Acrobat PDF.

Roger Bate is the Legatum Fellow in Global Prosperity at AEI. Emily Putze is a research assistant at AEI. Alexandra McPherson is at the Boston University School of Public Health. Sarah Naoshy is at the Boston University School of Public Health. Lorraine Mooney is a researcher, editor, economist and medical demographer at Africa Fighting Malaria.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate
  • Roger Bate is an economist who researches international health policy, with a particular focus on tropical disease and substandard and counterfeit medicines. He also writes on general development policy in Asia and Africa. He writes regularly for AEI's Health Policy Outlook.
  • Phone: 202-828-6029
    Email: rbate@aei.org
  • Assistant Info

    Name: Katherine Earle
    Phone: (202) 862-5872
    Email: katherine.earle@aei.org

What's new on AEI

image The money in banking: Comparing salaries of bank and bank regulatory employees
image What Obama should say about China in Japan
image A key to college success: Involved dads
image China takes the fight to space
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Event Registration is Closed
Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.